These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33570342)

  • 1. Chronic non-communicable diseases in the epidemic (COVID-19): Investigation of risk factors, control and care.
    Aleebrahim-Dehkordi E; Deravi N; Reyhanian A; Saberianpour S; Mokhtari M; Hasanpour-Dehkordi A
    Przegl Epidemiol; 2020; 74(3):449-456. PubMed ID: 33570342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19: Are Non-Communicable Diseases Risk Factors for Its Severity?
    Bello B; Useh U
    Am J Health Promot; 2021 Jun; 35(5):720-729. PubMed ID: 33576237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterizing a two-pronged epidemic in Mexico of non-communicable diseases and SARS-Cov-2: factors associated with increased case-fatality rates.
    Monterrubio-Flores E; Ramírez-Villalobos MD; Espinosa-Montero J; Hernandez B; Barquera S; Villalobos-Daniel VE; Campos-Nonato I
    Int J Epidemiol; 2021 May; 50(2):430-445. PubMed ID: 33585901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Risk of Hospitalization and Death in Patients with COVID-19 and Pre-existing Noncommunicable Diseases and Modifiable Risk Factors in Mexico.
    Hernández-Galdamez DR; González-Block MÁ; Romo-Dueñas DK; Lima-Morales R; Hernández-Vicente IA; Lumbreras-Guzmán M; Méndez-Hernández P
    Arch Med Res; 2020 Oct; 51(7):683-689. PubMed ID: 32747155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of socioeconomic and lifestyle factors with chronic non-communicable diseases and multimorbidity among the elderly in rural southwest China.
    Li X; Cai L; Cui WL; Wang XM; Li HF; He JH; Golden AR
    J Public Health (Oxf); 2020 May; 42(2):239-246. PubMed ID: 30860582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies to tackle non-communicable diseases in Afghanistan: A scoping review.
    Neyazi N; Mosadeghrad AM; Afshari M; Isfahani P; Safi N
    Front Public Health; 2023; 11():982416. PubMed ID: 36908476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-communicable disease, sociodemographic factors, and risk of death from infection: a UK Biobank observational cohort study.
    Drozd M; Pujades-Rodriguez M; Lillie PJ; Straw S; Morgan AW; Kearney MT; Witte KK; Cubbon RM
    Lancet Infect Dis; 2021 Aug; 21(8):1184-1191. PubMed ID: 33662324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19: implications for NCDs and the continuity of care in Sub-Saharan Africa.
    Owopetu O; Fasehun LK; Abakporo U
    Glob Health Promot; 2021 Jun; 28(2):83-86. PubMed ID: 33579179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal health and non-communicable disease prevention: An investment case for the post COVID-19 world and need for better health economic data.
    Kapur A; Hod M
    Int J Gynaecol Obstet; 2020 Aug; 150(2):151-158. PubMed ID: 32401348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrolevel association of COVID-19 with non-communicable disease risk factors in India.
    Gaur K; Khedar RS; Mangal K; Sharma AK; Dhamija RK; Gupta R
    Diabetes Metab Syndr; 2021; 15(1):343-350. PubMed ID: 33503583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of Non-communicable Diseases by Balanced Nutrition: Population- specific Effective Public Health Approaches in Developing Countries.
    Passi SJ
    Curr Diabetes Rev; 2017; 13(5):461-476. PubMed ID: 27593512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifactorial Basis and Therapeutic Strategies in Metabolism-Related Diseases.
    Guerra JVS; Dias MMG; Brilhante AJVC; Terra MF; García-Arévalo M; Figueira ACM
    Nutrients; 2021 Aug; 13(8):. PubMed ID: 34444990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-communicable diseases and related risk behaviors among men and women living with HIV in Cambodia: findings from a cross-sectional study.
    Chhoun P; Ngin C; Tuot S; Pal K; Steel M; Dionisio J; Pearson H; Mburu G; Brody C; Yi S
    Int J Equity Health; 2017 Jul; 16(1):125. PubMed ID: 28705242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 AND PRIMARY CARE: POSSIBILITIES FOR INCREASING POSITIVE OUTCOMES.
    Kurakh AV; Hechko MM; Chopey IV
    Wiad Lek; 2021; 74(10 cz 2):2659-2662. PubMed ID: 34923476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Covid-19 and non-communicable diseases: evidence from a systematic literature review.
    Nikoloski Z; Alqunaibet AM; Alfawaz RA; Almudarra SS; Herbst CH; El-Saharty S; Alsukait R; Algwizani A
    BMC Public Health; 2021 Jun; 21(1):1068. PubMed ID: 34090396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digital Health Tools for Managing Noncommunicable Diseases During and After the COVID-19 Pandemic: Perspectives of Patients and Caregivers.
    Monaco A; Palmer K; Holm Ravn Faber N; Kohler I; Silva M; Vatland A; van Griensven J; Votta M; Walsh D; Clay V; Yazicioglu MC; Ducinskiene D; Donde S
    J Med Internet Res; 2021 Jan; 23(1):e25652. PubMed ID: 33464206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic diseases and risk of symptomatic COVID-19: results of a case-population study on a sample of patients in the Local Health Unit 'Toscana Centro' (Tuscany Region, Central Italy)].
    Profili F; Ballo P; Balzi D; Bellini B; Bartalocci S; Zuppiroli A; Voller F; Francesconi P
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):308-314. PubMed ID: 33412823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing.
    Palmer K; Monaco A; Kivipelto M; Onder G; Maggi S; Michel JP; Prieto R; Sykara G; Donde S
    Aging Clin Exp Res; 2020 Jul; 32(7):1189-1194. PubMed ID: 32458356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk, burden, and management of non-communicable diseases in cerebral palsy: a scoping review.
    Ryan JM; Allen E; Gormley J; Hurvitz EA; Peterson MD
    Dev Med Child Neurol; 2018 Aug; 60(8):753-764. PubMed ID: 29572812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events.
    Nandy K; Salunke A; Pathak SK; Pandey A; Doctor C; Puj K; Sharma M; Jain A; Warikoo V
    Diabetes Metab Syndr; 2020; 14(5):1017-1025. PubMed ID: 32634716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.